Australia's expanding arena of peptide research and manufacturing is witnessing significant advancement, driven by both academic institutions and a number of niche companies. Significant research efforts are currently focused on designing novel therapeutic polypeptides for a variety of applications, including oncology, circulatory diseases, and ner